The Dutch health technology firm raises its outlook after reporting 4% comparable sales growth and improved margins.
Koninklijke Philips N.V. (PHG) forecast comparable sales growth of 3% to 4.5% and free cash flow between €1.5 billion and €1.7 billion for Q2 2026. The guidance reflects a tariff refund and aligns with earlier expectations amid a dynamic external environment.
The company reported 4% comparable sales growth in the latest period, with adjusted EBITA margins improving. Prior guidance had not specified free cash flow targets, but management cited operational resilience as a key driver.
No immediate market reaction was detailed in the earnings call summary.